|
|
Office Locations:
|
420 Boylston St. #501
Boston, MA 02116
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
New York Blood Center created NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies and technology. New York Blood Center established the fund with a $50M investment and a mission to improve patients' lives by advancing therapeutics, enabling platforms and technologies as well as driving collaborations to further NYBC's impact. For over 60 years, New York Blood Center has provided top-quality blood products and transfusion services.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
